- Home
- CAC vs EYPT Comparison
CAC vs EYPT Comparison
Compare CAC & EYPT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CAC
- EYPT
- Stock Information
- Founded
- CAC 1875
- EYPT 1987
- Country
- CAC United States
- EYPT United States
- Employees
- CAC N/A
- EYPT N/A
- Industry
- CAC Major Banks
- EYPT Biotechnology: Laboratory Analytical Instruments
- Sector
- CAC Finance
- EYPT Industrials
- Exchange
- CAC Nasdaq
- EYPT Nasdaq
- Market Cap
- CAC 688.3M
- EYPT 741.0M
- IPO Year
- CAC 1997
- EYPT 2005
- Fundamental
- Price
- CAC $39.80
- EYPT $13.60
- Analyst Decision
- CAC Buy
- EYPT Strong Buy
- Analyst Count
- CAC 3
- EYPT 6
- Target Price
- CAC $48.00
- EYPT $25.83
- AVG Volume (30 Days)
- CAC 55.1K
- EYPT 767.8K
- Earning Date
- CAC 10-28-2025
- EYPT 11-06-2025
- Dividend Yield
- CAC 4.17%
- EYPT N/A
- EPS Growth
- CAC 4.80
- EYPT N/A
- EPS
- CAC 3.11
- EYPT N/A
- Revenue
- CAC $197,501,000.00
- EYPT $51,898,000.00
- Revenue This Year
- CAC $42.11
- EYPT N/A
- Revenue Next Year
- CAC $5.51
- EYPT N/A
- P/E Ratio
- CAC $12.93
- EYPT N/A
- Revenue Growth
- CAC 21.74
- EYPT 2.99
- 52 Week Low
- CAC $34.53
- EYPT $3.91
- 52 Week High
- CAC $50.07
- EYPT $14.42
- Technical
- Relative Strength Index (RSI)
- CAC 47.42
- EYPT 65.67
- Support Level
- CAC $39.82
- EYPT $12.88
- Resistance Level
- CAC $40.75
- EYPT $14.42
- Average True Range (ATR)
- CAC 0.79
- EYPT 0.78
- MACD
- CAC -0.06
- EYPT 0.05
- Stochastic Oscillator
- CAC 12.06
- EYPT 74.05
About CAC Camden National Corporation
Camden National Corporation is a banking solutions provider in the United States. Its core business is providing commercial banking products to individuals and corporates. Its consumer and commercial banking services entail services such as loans and deposits, savings and online banking, treasury management solutions and non-profit products to consumer, institutional, municipal, non-profit and commercial customers. The company also offers investment management and fiduciary services.
About EYPT EyePoint Pharmaceuticals Inc.
EyePoint Pharmaceuticals Inc is a pharmaceutical company. It is engaged in developing and commercializing ophthalmic products for the treatment of eye diseases. The company has developed FDA-approved sustained-release treatments in ophthalmology. Its pre-clinical development program is focused on using its core Durasert E and Verisome technology platforms to deliver drugs to treat wet age-related macular degeneration, glaucoma, osteoarthritis, and other diseases. Geographically, the firm has operational footprints in the U.S., China, and the UK. It generates a majority of its revenue from the U.S.